Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.57 Million ≈ $2.28 Million USD) by net assets (CN¥5.73 Billion ≈ $838.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002932 market cap overview for the company's overall valuation and market capitalisation.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Wuhan Easy Diagnosis Biomedicine Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Wuhan Easy Diagnosis Biomedicine Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A ranked by their cash flow conversion efficiency. Explore Wuhan Easy Diagnosis Biomedicine Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	0.010x
Zhejiang Sf Oilless Bearing Co Ltd SHE:300817	0.053x
NioCorp Developments Ltd. Common Stock NASDAQ:NB	-0.010x
AGI Greenpac Limited NSE:AGI	-0.035x
Csd Water Service Co Ltd SHG:603903	0.110x
Movado Group Inc NYSE:MOV	0.014x
Cachet Pharmaceutical Co Ltd SHE:002462	0.078x
China National Complete Plant Import & Export Corp Ltd SHE:000151	0.042x

Annual Cash Flow Conversion Efficiency for Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (2011–2025)

The table below shows the annual cash flow conversion efficiency of Wuhan Easy Diagnosis Biomedicine Co Ltd Class A from 2011 to 2025. View 002932 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥5.66 Billion ≈ $827.62 Million	CN¥-70.05 Million ≈ $-10.25 Million	-0.012x	+12.34%
2024-12-31	CN¥6.02 Billion ≈ $880.72 Million	CN¥-85.05 Million ≈ $-12.44 Million	-0.014x	-122.65%
2023-12-31	CN¥6.29 Billion ≈ $920.73 Million	CN¥392.50 Million ≈ $57.43 Million	0.062x	-89.47%
2022-12-31	CN¥6.77 Billion ≈ $990.93 Million	CN¥4.01 Billion ≈ $587.21 Million	0.593x	+49.86%
2021-12-31	CN¥2.85 Billion ≈ $417.06 Million	CN¥1.13 Billion ≈ $164.92 Million	0.395x	+22.57%
2020-12-31	CN¥1.11 Billion ≈ $163.14 Million	CN¥359.68 Million ≈ $52.63 Million	0.323x	+783.28%
2019-12-31	CN¥615.62 Million ≈ $90.08 Million	CN¥22.49 Million ≈ $3.29 Million	0.037x	-59.67%
2018-12-31	CN¥592.59 Million ≈ $86.72 Million	CN¥53.67 Million ≈ $7.85 Million	0.091x	-52.68%
2017-12-31	CN¥242.93 Million ≈ $35.55 Million	CN¥46.50 Million ≈ $6.80 Million	0.191x	-43.07%
2016-12-31	CN¥175.08 Million ≈ $25.62 Million	CN¥58.86 Million ≈ $8.61 Million	0.336x	-13.84%
2015-12-31	CN¥115.39 Million ≈ $16.89 Million	CN¥45.02 Million ≈ $6.59 Million	0.390x	+17.45%
2014-12-31	CN¥49.59 Million ≈ $7.26 Million	CN¥16.47 Million ≈ $2.41 Million	0.332x	-28.26%
2013-12-31	CN¥13.60 Million ≈ $1.99 Million	CN¥6.30 Million ≈ $921.32K	0.463x	-36.17%
2012-12-31	CN¥1.42 Million ≈ $208.28K	CN¥1.03 Million ≈ $151.10K	0.725x	+103.22%
2011-12-31	CN¥21.45K ≈ $3.14K	CN¥-482.90K ≈ $-70.66K	-22.514x	--

About Wuhan Easy Diagnosis Biomedicine Co Ltd Class A

SHE:002932 China Medical Devices

Market Cap

$520.92 Million

CN¥3.56 Billion CNY

Market Cap Rank

#12140 Global

#3523 in China

Share Price

CN¥15.31

Change (1 day)

-0.07%

52-Week Range

CN¥13.85 - CN¥20.47

All Time High

CN¥49.58